Florida Atlantic University was founded in 1961, in Boca Raton on an 850-acre site located near the Atlantic Ocean. The campus is conveniently located halfway between Palm Beach and Fort Lauderdale and offers a broad range of academic programs, activities, and services.

The Boca Raton campus provides an exciting and supportive learning environment for students. The Student Union hosts student activities and meetings. In addition, its 2,500-seat Carole and Barry Kaye Performing Arts Auditorium enables students to enjoy performances ranging from rock bands to the Florida Philharmonic Orchestra. The campus supports two cafeterias and has an attractive array of accommodations for its residential students. The Boca Raton campus is also home to FAU's Division I Intercollegiate Athletics program and facilities. Its recreation complex includes an aquatic center, gymnasium, tennis courts, wellness center, track, and a variety of fields for club and intramural sports competition.

The five-story S.E. Wimberly Library houses a large collection of monographs, serials, and other academic resources. Computer labs, study lounges, a media center, and tutoring services also provide valuable academic support for students. The Boca Raton campus hosts art exhibits, theatre productions, and concerts in its two galleries and theatre. Visiting performers and speakers add to the artistic and intellectual vibrancy of the campus.

Florida Atlantic University

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

Meritorious Service Medal

American College of Healthcare Executives

American Neurological Association

Hemorrhagic stroke outcomes of KApSR patients with co-morbid diabetes and Alzheimer’s disease

Abstract P885: Sex-Based Differences of Cerebral Venous Sinus Thrombosis Patients in the Appalachian Region

Toxin-induced cerebellar disorders

Next Steps for Clinical Neurotoxicology

Neurotoxicity and Chemoreception: A Systematic Review of Neurotoxicity Effects on Smell and Taste

Applied Neurotoxicology, An Issue of Neurologic Clinics (Volume 38-4) (The Clinics: Internal Medicine, Volume 38-4)

Michael Dobbs, M.D., is an expert in vascular neurology, particularly the pathophysiology and treatment of amyloidosis – a life-threatening condition characterized by the accumulation of amyloid proteins in various organs, including the brain. He is dedicated to advancing understanding of amyloid fibril formation and exploring therapeutic strategies to dissolve existing deposits. Dobbs is also a prolific author in the field of neurotoxicology. His book, "Applied Neurotoxicology," serves as a practical guide for clinicians to recognize and manage neurotoxic exposures, addressing a critical gap in medical education and practice. Dobbs is instrumental in fostering collaborative research and clinical initiatives aimed at improving patient outcomes in neurology.

Vascular Neurology

Neurotoxicology

Amyloidosis

Amyloid Fibril Formation

Quality of Care

Healthcare Management

Physician Relations

Faculty Page

Google Scholar

New drug gives hope to South Floridians affected by Alzheimer’s

Understanding Alzheimer's Disease: the Basics

Composition and method for control and treatment of cutaneous inflammation

Chair of the Clinical Neurosciences Department

Michael R. Dobbs, MD, MHCM is Vice-dean of Clinical Affairs and a tenured Professor and Chair of Neurology at UTRGV. He is also module co-director for Mind, Brain, and Behavior in the 2nd year medical student curriculum.  As Chief Medical Officer at UT Health RGV, Dobbs shares oversight of the practice plan and the medical staff and he is currently working on long-term clinical strategy for UT Health RGV.     

He moved to UTRGV from the University of Kentucky where he served as an Associate Dean responsible for clinical and statewide initiatives, Associate Chief Medical officer, and Interim Chair of Neurology.  A stroke neurologist, he founded and built the 34 hospital UK Healthcare/Norton Healthcare Stroke Network that continues to grow and bring life-saving treatments to underserved regions.  He led a team that created a novel data management system, the Kentucky-Appalachian Stroke Registry, which fuels clinical trials and original publications.  He helped to create the sub-specialty of Clinical Neurotoxicology, and his textbook Clinical Neurotoxicology—Syndromes, Substances, Environments is a leading reference text in the field. He also holds a patent for a dermatitis treatment that made it to the veterinary market and has provided relief to millions of small animals as “Genesis Topical Spray.”  

He has taught in the classroom on topics as wide-ranging as financial management and art history.  He holds degrees from the University of Kentucky and Harvard. He served with distinction in the US Air Force.  In his spare time, he loves to be with his family and paint landscapes.

COVID Decoded Part 1: Opening Remarks &amp; Keynote by Dr. Michael Dobbs

With the holidays around the corner, it’s important that we continue observing safety guidelines.


One of the key precautions from Dr. Dobbs is to not become someone who has been around someone who’s COVID positive for 15 minutes in a 24-hour period, also known as close contact.

"COVID-19 Health Guidelines" with Michael Dobbs, MD | UT Health RGV

By the time we’re born as babies, our brain has already done a lot of its development. We learn language, develop our personality, and learn a lot of skills, so protecting the vulnerable brain is important during gestation but remains vital throughout our lives.


Dr. Michael Dobbs, Chief Medical Officer and Neurologist, talked to us about how we can take care of our brain, our baby’s brain, and the on-going research projects that UTRGV and UTRGV SOM are leading to offer the best possible treatments for brain-related disorders, as well as the upcoming opening of our very own Neuroscience Institute.

"Brain Awareness Week" with Michael Dobbs, MD | UT Health RGV

Media Inquiry